|
000
| 01029nam##2200265za#4500 |
|---|
| 001 | 9.554472 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210305151654 |
|---|
| 007 | ta |
|---|
| 008 | 150406|2011||||xxc||||| f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | |aeng |
|---|
| 041 | |afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aXB411-221/1 |
|---|
| 110 | 1 |aCanada. |bParliament. |bHouse of Commons. |
|---|
| 245 | 13|aAn Act respecting a Comprehensive National Strategy for Sickle Cell Disease and Thalassemic Disorders|cMs. Duncan (Etobicoke North). |
|---|
| 246 | 1 |iShort title : |aNational Strategy for Sickle Cell Disease and Thalassemic Disorders Act |
|---|
| 260 | |aOttawa - Ontario : |bHouse of Commons |cFirst reading, June 15, 2011. |
|---|
| 300 | |a3p. ; |c28 cm. |
|---|
| 490 | 1 |aHouse of Commons of Canada bill|vC-221 |
|---|
| 563 | |aProcessed |
|---|
| 590 | |a11-27|b2011-07-08 |
|---|
| 792 | |tLoi concernant une stratégie nationale globale sur la drépanocytose et les thalassémies|w(CaOODSP)9.554473 |
|---|
| 830 | #0|aHouse of Commons of Canada bill ;|vC-221|w(CaOODSP)9.512274 |
|---|